Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

Similar articles for PubMed (Select 23514246)

1.

Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.

Nichols AC, Yoo J, Hammond JA, Fung K, Winquist E, Read N, Venkatesan V, MacNeil SD, Ernst DS, Kuruvilla S, Chen J, Corsten M, Odell M, Eapen L, Theurer J, Doyle PC, Wehrli B, Kwan K, Palma DA.

BMC Cancer. 2013 Mar 20;13:133. doi: 10.1186/1471-2407-13-133.

2.
3.

Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma.

Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS.

Arch Otolaryngol Head Neck Surg. 2011 Nov;137(11):1112-6. doi: 10.1001/archoto.2011.172.

PMID:
22106235
4.

Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.

White H, Ford S, Bush B, Holsinger FC, Moore E, Ghanem T, Carroll W, Rosenthal E, Sweeny L, Magnuson JS.

JAMA Otolaryngol Head Neck Surg. 2013 Aug 1;139(8):773-8. doi: 10.1001/jamaoto.2013.3866. Erratum in: JAMA Otolaryngol Head Neck Surg.n 2013 Dec;139(12):1290. Sweeny, Larissa [added].

PMID:
23949352
5.

Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes.

Dziegielewski PT, Teknos TN, Durmus K, Old M, Agrawal A, Kakarala K, Marcinow A, Ozer E.

JAMA Otolaryngol Head Neck Surg. 2013 Nov;139(11):1099-108. doi: 10.1001/jamaoto.2013.2747.

6.

Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.

Fallai C, Bolner A, Signor M, Gava A, Franchin G, Ponticelli P, Taino R, Rossi F, Ardizzoia A, Oggionni M, Crispino S, Olmi P.

Tumori. 2006 Jan-Feb;92(1):41-54.

PMID:
16683383
7.

Transoral robotic surgery for supraglottic squamous cell carcinoma.

Olsen SM, Moore EJ, Koch CA, Price DL, Kasperbauer JL, Olsen KD.

Am J Otolaryngol. 2012 Jul-Aug;33(4):379-84. doi: 10.1016/j.amjoto.2011.10.007. Epub 2011 Nov 30.

PMID:
22133967
8.

The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.

O'Brien CJ, Traynor SJ, McNeil E, McMahon JD, Chaplin JM.

Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):360-5.

PMID:
10722009
9.

Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE, Macluskey M, Chan KK, Conway DI; CSROC Expert Panel.

Cochrane Database Syst Rev. 2010 Sep 8;(9):CD006386. doi: 10.1002/14651858.CD006386.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(4):CD006386.

PMID:
20824847
10.

Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review.

Kelly K, Johnson-Obaseki S, Lumingu J, Corsten M.

Oral Oncol. 2014 Aug;50(8):696-703. doi: 10.1016/j.oraloncology.2014.04.005. Epub 2014 Jun 7. Review.

PMID:
24917389
11.

Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE, Macluskey M, Chan KK, Conway DI.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006386. doi: 10.1002/14651858.CD006386.pub3. Review.

PMID:
21491393
12.

Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.

Haughey BH, Sinha P.

Laryngoscope. 2012 Sep;122 Suppl 2:S13-33. doi: 10.1002/lary.23493.

PMID:
22926949
13.

Outcomes of transoral robotic surgery: a preliminary clinical experience.

Hurtuk A, Agrawal A, Old M, Teknos TN, Ozer E.

Otolaryngol Head Neck Surg. 2011 Aug;145(2):248-53. doi: 10.1177/0194599811402172.

14.
15.
16.

Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.

Olmi P, Crispino S, Fallai C, Torri V, Rossi F, Bolner A, Amichetti M, Signor M, Taino R, Squadrelli M, Colombo A, Ardizzoia A, Ponticelli P, Franchin G, Minatel E, Gobitti C, Atzeni G, Gava A, Flann M, Marsoni S.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):78-92.

PMID:
12504039
17.

Functional and oncological results of non-surgical vs surgical treatment in squamous cell carcinomas of the oropharynx.

Díaz-Molina JP, Rodrigo JP, Alvarez-Marcos C, Blay P, de la Rúa A, Estrada E, Alonso R.

Acta Otorrinolaringol Esp. 2012 Sep-Oct;63(5):348-54. doi: 10.1016/j.otorri.2012.02.005. Epub 2012 Apr 12. English, Spanish.

18.

Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers.

More YI, Tsue TT, Girod DA, Harbison J, Sykes KJ, Williams C, Shnayder Y.

JAMA Otolaryngol Head Neck Surg. 2013 Jan;139(1):43-8. doi: 10.1001/jamaoto.2013.1074. Erratum in: JAMA Otolaryngol Head Neck Surg. 2013 Mar;139(3):292.

PMID:
23247974
19.

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.

Lee DJ, Cosmatos D, Marcial VA, Fu KK, Rotman M, Cooper JS, Ortiz HG, Beitler JJ, Abrams RA, Curran WJ, et al.

Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):567-76.

PMID:
7790241
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk